Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
S Abraham Gnanadass, Y Divakar Prabhu… - Archives of Gynecology …, 2021 - Springer
Background Polycystic ovarian syndrome (PCOS) is the most prevalent metabolic disorder
in reproductive-age women. It is indeed a multifactorial condition evidenced by ovarian …
in reproductive-age women. It is indeed a multifactorial condition evidenced by ovarian …
Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
Y Sun, S Gao, C Ye, W Zhao - Frontiers in cellular and infection …, 2023 - frontiersin.org
Polycystic ovary syndrome (PCOS) is the most common endocrine diseases in women of
childbearing age that leads to menstrual disorders and infertility. The pathogenesis of PCOS …
childbearing age that leads to menstrual disorders and infertility. The pathogenesis of PCOS …
The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review
SG Vitale, AM Fulghesu, M Mikuš, R Watrowski… - Biomedicines, 2022 - mdpi.com
MicroRNAs (miRNAs) are small, non-coding RNAs that are essential for the regulation of
post-transcriptional gene expression during tissue development and differentiation. They are …
post-transcriptional gene expression during tissue development and differentiation. They are …
[HTML][HTML] CXC chemokines influence immune surveillance in immunological disorders: Polycystic ovary syndrome and endometriosis
A Ullah, MJ Wang, YX Wang, B Shen - Biochimica et Biophysica Acta (BBA) …, 2023 - Elsevier
Reproductive health is a worldwide challenge, but it is of particular significance to women
during their reproductive age. Several female reproductive problems, including polycystic …
during their reproductive age. Several female reproductive problems, including polycystic …
Metformin as a potential agent in the treatment of multiple sclerosis
A Dziedzic, J Saluk-Bijak, E Miller, M Bijak - International Journal of …, 2020 - mdpi.com
Metformin, a synthetic derivative of guanidine, is commonly used as an oral antidiabetic
agent and is considered a multi-vector application agent in the treatment of other …
agent and is considered a multi-vector application agent in the treatment of other …
The immune system's role in PCOS
M Shamsi, A Ghazavi, AM Saeedifar… - Molecular Biology …, 2022 - Springer
Polycystic ovary syndrome (PCOS) is a common disorder of the endocrine system. Its main
manifestations include oligo-ovulation, hyperandrogenism, and polycystic ovary morphology …
manifestations include oligo-ovulation, hyperandrogenism, and polycystic ovary morphology …
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial …
JY Zhao, XL Sheng, CJ Li, T Qin, RD He… - Neural Regeneration …, 2023 - journals.lww.com
Abstract Treatment with metformin can lead to the recovery of pleiotropic biological activities
after spinal cord injury. However, its effect on spinal cord injury in aged mice remains …
after spinal cord injury. However, its effect on spinal cord injury in aged mice remains …
The implication of mechanistic approaches and the role of the microbiome in polycystic ovary syndrome (PCOS): a review
AG Mukherjee, UR Wanjari, S Kannampuzha, R Murali… - Metabolites, 2023 - mdpi.com
As a complex endocrine and metabolic condition, polycystic ovarian syndrome (PCOS)
affects women's reproductive health. These common symptoms include hirsutism …
affects women's reproductive health. These common symptoms include hirsutism …
Metformin downregulates PD-L1 expression in esophageal squamous cell carcinoma by inhibiting IL-6 signaling pathway
Y Lu, D Xin, L Guan, M Xu, Y Yang, Y Chen… - Frontiers in …, 2021 - frontiersin.org
Purpose To characterize the mechanism by which metformin inhibits PD-L1 expression in
esophageal squamous cell carcinoma (ESCC) and to evaluate the effect of metformin on the …
esophageal squamous cell carcinoma (ESCC) and to evaluate the effect of metformin on the …
Pioglitazone attenuates the effects of peripheral inflammation in a human in vitro blood–brain barrier model
Biological mediators secreted during peripheral chronic inflammation reach the bloodstream
and may damage the blood–brain barrier (BBB), triggering central nervous system (CNS) …
and may damage the blood–brain barrier (BBB), triggering central nervous system (CNS) …